{"id":30567,"date":"2023-12-02T22:07:35","date_gmt":"2023-12-03T03:07:35","guid":{"rendered":"https:\/\/ckms.ca\/?p=30567"},"modified":"2023-12-02T22:07:35","modified_gmt":"2023-12-03T03:07:35","slug":"maker-of-wegovy-ozempic-showers-money-on-u-s-obesity-doctors","status":"publish","type":"post","link":"https:\/\/blog.ckms.ca\/?p=30567","title":{"rendered":"Maker of Wegovy, Ozempic showers money on U.S. obesity doctors"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"hoverZoomLink alignright\" src=\"https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/health-obesity-novonordisk-doctors_28.jpg\" alt=\"\" width=\"209\" height=\"139\" \/><span style=\"font-size: inherit;\">Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans.<\/span><\/p>\n<p>Source: <em><a href=\"https:\/\/www.reuters.com\/investigates\/special-report\/health-obesity-novonordisk-doctors\/\">Maker of Wegovy, Ozempic showers money on U.S. obesity doctors<\/a><\/em><\/p>\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p>so much money to be made&#8230;<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&#8220;Novo tells investors its target market is the 764 million people with obesity across the globe. Its most lucrative region is the United States, where more than two-thirds of adults are overweight or have obesity\u00a0and drugs frequently command the highest prices worldwide. Novo charges U.S. customers $1,300 a month for the weekly injection.&#8221;<\/p><\/blockquote>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image.png\"><img loading=\"lazy\" decoding=\"async\" width=\"888\" height=\"838\" src=\"https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image.png\" alt=\"\" class=\"wp-image-30570\" srcset=\"https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image.png 888w, https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image-300x283.png 300w, https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image-768x725.png 768w, https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image-750x708.png 750w, https:\/\/blog.ckms.ca\/wp-content\/uploads\/2023\/12\/image-675x637.png 675w\" sizes=\"auto, (max-width: 888px) 100vw, 888px\" \/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[488,1787,1866],"class_list":["post-30567","post","type-post","status-publish","format-standard","hentry","category-article","tag-invest","tag-ozempic","tag-weight","wpcat-282-id"],"_links":{"self":[{"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=\/wp\/v2\/posts\/30567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30567"}],"version-history":[{"count":2,"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=\/wp\/v2\/posts\/30567\/revisions"}],"predecessor-version":[{"id":30571,"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=\/wp\/v2\/posts\/30567\/revisions\/30571"}],"wp:attachment":[{"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.ckms.ca\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}